Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors

Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors

INTRODUCTION. Marburg and Ebola viruses cause severe haemorrhagic fever in humans and primates. Currently, there are no licensed prophylactic vaccines that can simultaneously prevent the spread or reduce the severity of both diseases caused by these filoviruses. The development of effective prophyla...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: T. A. Ozharovskaia, O. V. Zubkova, O. Popova, A. V. Kovyrshina, P. P. Goldovskaya, I. V. Vavilova, I. V. Dolzhikova, E. I. Ermolova, M. S. Kunda, N. N. Ryzhova, O. L. Voronina, D. N. Shcherbinin, D. V. Shcheblyakov, D. Y. Logunov, A. L. Gintsburg
Natura: Articolo
Lingua:russo
Pubblicazione: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-10-01
Serie:Биопрепараты: Профилактика, диагностика, лечение
Soggetti:
immunogenicity
glycoprotein gene variants
ebola virus
marburg virus
human adenovirus type 5
recombinant adenoviral vectors
ebola virus disease
marburg virus disease
humoral immune response
Accesso online:https://www.biopreparations.ru/jour/article/view/576
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Entra per informazioni su prenotazioni e richieste

Accesso online

https://www.biopreparations.ru/jour/article/view/576

Documenti analoghi